about
Nanoparticle-mediated drug delivery for treating melanomaHER2 expression beyond breast cancer: therapeutic implications for gynecologic malignanciesOptimal management of metastatic melanoma: current strategies and future directionsImmunotherapy in gastric cancerPost-embryonic nerve-associated precursors to adult pigment cells: genetic requirements and dynamics of morphogenesis and differentiationAdjuvants for peptide-based cancer vaccinesTargeting the VEGF-C/VEGFR3 axis suppresses Slug-mediated cancer metastasis and stemness via inhibition of KRAS/YAP1 signalingDownregulation of tumor growth and invasion by redox-active nanoparticlesProspective study of the evolution of blood lymphoid immune parameters during dacarbazine chemotherapy in metastatic and locally advanced melanoma patientsAlpha-catulin contributes to drug-resistance of melanoma by activating NF-κB and AP-1Long-term outcomes of helper peptide vaccination for metastatic melanoma.A possible cross-talk between autophagy and apoptosis in generating an immune response in melanomaSystemic delivery of nanoparticle formulation of novel tubulin inhibitor for treating metastatic melanoma.An artificial miRNA against HPSE suppresses melanoma invasion properties, correlating with a down-regulation of chemokines and MAPK phosphorylation.Results of systemic treatment of cutaneous melanoma in inoperable stage III and IVSafety and efficacy of suicide gene therapy with adenosine deaminase 5-fluorocytosine silmutaneously in in vitro cultures of melanoma and retinal cell lines.miR-185 enhances the inhibition of proliferation and migration induced by ionizing radiation in melanoma.Improving anticancer efficacy of (-)-epigallocatechin-3-gallate gold nanoparticles in murine B16F10 melanoma cellsTreatment patterns in patients with metastatic melanoma: a retrospective analysis.β-Lapachone suppresses the lung metastasis of melanoma via the MAPK signaling pathway.Metastatic malignant melanoma with peritoneal seeding in a young woman: A case reportInhibition of melanoma growth by subcutaneous administration of hTERTC27 viral cocktail in C57BL/6 mice.Activated Natural Killer Cells Mediate the Suppressive Effect of Interleukin-4 on Tumor Development via STAT6 Activation in an Atopic Condition Melanoma Model.Primary extramedullary spinal melanoma mimicking spinal meningioma: A case report and literature reviewMembrane transport proteins in human melanoma: associations with tumour aggressiveness and metastasis.Human proangiogenic circulating hematopoietic stem and progenitor cells promote tumor growth in an orthotopic melanoma xenograft model.Enhancement of electroporation facilitated immunogene therapy via T-reg depletion.AMP-activated kinase (AMPK)-generated signals in malignant melanoma cell growth and survival.Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing bcl-xl, bcl-2, and mcl-1Cholesterol depletion by methyl-β-cyclodextrin augments tamoxifen induced cell death by enhancing its uptake in melanoma.Mitogen-activated protein kinase (MAPK) hyperactivation and enhanced NRAS expression drive acquired vemurafenib resistance in V600E BRAF melanoma cells.Novel multiple markers to distinguish melanoma from dysplastic nevi.Inhibition of melanoma development in the Nras((Q61K)) ::Ink4a(-/-) mouse model by the small molecule BI-69A11.LFA-1 and ICAM-1 expression induced during melanoma-endothelial cell co-culture favors the transendothelial migration of melanoma cell lines in vitroMelanoma cells show a heterogeneous range of sensitivity to ionizing radiation and are radiosensitized by inhibition of B-RAF with PLX-4032.Intertissue flow of glutathione (GSH) as a tumor growth-promoting mechanism: interleukin 6 induces GSH release from hepatocytes in metastatic B16 melanoma-bearing mice.Central nervous system failure in melanoma patients: results of a randomised, multicentre phase 3 study of temozolomide- and dacarbazine- based regimens.Methylation levels of the "long interspersed nucleotide element-1" repetitive sequences predict survival of melanoma patientsMelanoma: Molecular Pathogenesis and Therapeutic ManagementFolated synperonic-cholesteryl hemisuccinate polymeric micelles for the targeted delivery of docetaxel in melanoma.
P2860
Q26798379-746A3FAF-5E96-42D5-A9A0-B0D6A50EDFDDQ26822730-A785CBA7-9459-470F-87BC-64EDA34AD374Q26997338-79F9754F-2160-4472-AF5C-ABE5B0C4F7C2Q27010472-92F5C71C-59A2-47CA-91B6-E6DCD3B3C7BDQ27341771-6956E14D-1F31-424A-93B5-5ECFE3C147B6Q28072236-9AE8F7AB-F767-4AE4-86FD-3A7DD9F6E00EQ28078716-4557112A-EB09-4DA5-82A7-62E5DEFC37DAQ28387744-2A5BA5CC-2A91-4CD4-A7CE-413F20F7CA5CQ28542660-A434A67D-DAA8-49B4-8097-C849CD68CBCFQ28544808-154F0929-CBAD-4E86-922A-1C6E67398D46Q30278874-747E0B27-9B50-41DA-8D19-35CA4D44A324Q30416873-A1E42F6A-44E9-4F1C-8A8E-950E5CD74A4DQ30940472-2997243E-93C2-454D-8BC5-F72EF7C6D951Q31066444-32A180CD-D5C9-4279-A4EE-E9505BF285EAQ33408564-B3E5AC25-AB8A-493F-B482-02BB3BFE34ABQ33556564-5AC4BFE8-8350-493A-9BC1-0EB572BFDF55Q33597730-B37B12BA-CD1D-473D-A506-83DE56F16335Q33610434-C0FA741B-7C23-4D9D-8EA4-139F7821C5CFQ33634914-E13F9127-190A-40FE-830D-9483A5837C6DQ33648101-CF048262-9562-4F04-B4DA-ACCD3B4F0622Q33686532-0CA9F067-EE04-4994-8B06-224855CA10CFQ33698116-347E1074-C2C1-4A43-8C1E-7E699317854CQ33765161-5BACFFF8-8452-4FD5-A7CC-7C0353A0CDFAQ33778544-71DE1FD4-8BBB-4855-87D7-4C57CDFBC330Q33783032-2CCD8F35-12E8-4A37-A06D-E18827F6AB66Q34026969-8B6575F0-CF20-4275-9A6E-BE16BBCA1B2CQ34072036-B2E4F42A-B391-4780-9F22-B5EDA96687DEQ34081105-232856F0-69C4-4415-96BB-6F40BD785F55Q34123184-1E931440-1EF6-4018-B2A3-E41D7BA86E29Q34246496-D9A3B1D0-745D-4174-B9F9-A7168A8573D9Q34283481-DD54CD0B-8F1E-48B1-BB8E-1606944C3C76Q34427923-1ED8C463-0612-456B-AF4E-F3E31ABB950EQ34433459-CD907BE2-8E00-4EB0-8A8A-D1FA4628CE64Q34435046-22897F62-3463-4336-9713-398A2867AE2CQ34634256-5009DD27-240D-4636-B424-BC0134AEEE51Q34962993-199FE13B-1481-4A67-8EBF-7688D56C0E73Q35034764-6F5535B6-A55B-4E74-8FF4-933D0CE519A0Q35069309-0950383E-E2AC-426F-AC00-FA61006DD067Q35137163-99CB7D4F-B67B-46F6-B670-F6BCC7CF81E2Q35207269-EDF6A59B-7F5F-4742-B85F-BE67F7FBDE1A
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Treatment of metastatic melanoma: an overview
@ast
Treatment of metastatic melanoma: an overview
@en
Treatment of metastatic melanoma: an overview
@nl
type
label
Treatment of metastatic melanoma: an overview
@ast
Treatment of metastatic melanoma: an overview
@en
Treatment of metastatic melanoma: an overview
@nl
prefLabel
Treatment of metastatic melanoma: an overview
@ast
Treatment of metastatic melanoma: an overview
@en
Treatment of metastatic melanoma: an overview
@nl
P2093
P2860
P3181
P1433
P1476
Treatment of metastatic melanoma: an overview
@en
P2093
John A Thompson
Scott S Tykodi
Shailender Bhatia
P2860
P304
P3181
P407
P577
2009-05-01T00:00:00Z